Could a diabetes drug help fight sarcoma? new trial explores metformin's potential

NCT ID NCT07291297

Recruiting now Disease control Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether adding metformin, a common diabetes medicine, to standard cancer treatment can help people with advanced soft tissue sarcoma live longer. About 50 adults whose cancer has spread or cannot be removed will take metformin along with their usual therapy. The main goal is to see how many are still alive after 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOMA, SOFT TISSUE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sarcoma soft tissue sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SARCOMA METASTATIC SARCOMA, SOFT TISSUE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Atrium Health Wake Forest Baptist Comprehensive Cancer Center
RECRUITING

Winston-Salem, North Carolina, 27103, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Levine Cancer Institute
RECRUITING

Charlotte, North Carolina, 28204, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact